# Benef: __Tailored protection for symptomatic and asymptomatic patients__ (PBN__Benef_1189)

## Property: has_Beneficiary

* [reinfected patients with and without symptoms](../Stakeholder/PBN__Stakeholder_464)

## Property: has_BenefDetails

Evaluating differences in efficacy based on symptoms allows for tailored protection strategies, ensuring appropriate measures are taken for each group

## Property: has_BenefSource

* [pilz_contributions_2022](../Article/PBN__Article_245)

## Property: has_BenefReturn

* [Private investors can invest in research to develop targeted protection measures, potentially leading to the development of new therapeutics or improved vaccine strategies.](../BenefReturn/PBN__BenefReturn_1325)

